Frazier Life Sciences

Frazier Healthcare Partners is a leading private equity and venture capital firm that focuses exclusively on the healthcare sector. Established in 1991, the firm has raised over $7.1 billion in total capital and invested in more than 200 companies. Frazier Healthcare operates through two primary divisions: Growth Buyout and Life Sciences. The Growth Buyout division invests in profitable U.S. middle-market healthcare businesses, providing capital for growth and transformation. The Life Sciences division focuses on private and publicly traded companies that discover, develop, and commercialize innovative biopharmaceuticals. Recent notable exits include ARMO BioSciences (acquired by Eli Lilly) and Translate Bio (acquired by Sanofi)​. Frazier Healthcare Partners is headquartered in Menlo Park, California, with additional offices in Seattle, Washington. The firm's team comprises seasoned professionals with deep industry expertise, including Managing Partners Albert Cha, Patrick Heron, and James Topper.